P110027S013

None

FDA Premarket Approval P110027 S013

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP110027S013
Classification NameNone
Applicant
PMAP110027
SupplementS013

Supplemental Filings

Supplement NumberDateSupplement Type
P110027Original Filing
S015 2022-06-15 30-day Notice
S014 2022-05-19 Special (immediate Track)
S013
S012 2021-02-10 Panel Track
S011 2020-03-04 30-day Notice
S010 2018-03-08 30-day Notice
S009 2015-08-18 Normal 180 Day Track No User Fee
S008 2015-02-18 Normal 180 Day Track
S007 2015-01-26 Real-time Process
S006 2015-01-26 Real-time Process
S005 2015-01-21 30-day Notice
S004 2015-01-21 30-day Notice
S003 2014-12-22 30-day Notice
S002 2014-12-15 30-day Notice
S001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.